Can-Fite BioPharma Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Other
Can-Fite BioPharma Ltd. (CANF) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Other of 27.00 million shares for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther · last filed 2023-03-30
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Other 12 month |
|---|---|
| 2022-12-31 | 27.00M shares 20-F · filed 2023-03-30 |